Urgent.News

What's breaking now, across thousands of outlets.

Business

Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy

Novo says Lilly's TV and social media campaigns cite outdated trial data to make Zepbound and Mounjaro look more effective than rival injections

Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at qz.com →

More in Business

More from Friday 16 October →